A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

NCT05183646 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

286

Enrollment

INDUSTRY

Sponsor class

Conditions

FSGS

Interventions

DRUG: DMX-200
DRUG: Placebo

Sponsor

Dimerix Bioscience Pty Ltd